Assessment of Flow With the New Four-dimensional Velocity-encoded Magnetic Resonance Imaging Technique
NCT ID: NCT02952287
Last Updated: 2021-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
100 participants
INTERVENTIONAL
2016-11-30
2021-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
4D Velocity Mapping of the Heart in rTOF Patients
NCT02980614
Imaging by 4 DFlow in Patients With Tetralogy of Fallot
NCT03542968
Cardiovascular Imaging in Pediatric Myocarditis
NCT06652399
Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
NCT06641843
Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers
NCT00353899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Participants
4D PC MRI acquisition
4D PC MRI acquisition
Flow-sensitive 4D-MRI acquisitions will be synchronized to the heart rate and breathing using prospective ECG-gating and adaptive diaphragm navigator gating41. The MRI sequence will consist of a segmented k-space spoiled gradient echo sequence with interleaved 3D velocity encoding. Data will be acquired in a sagittal oblique 3D data volume individually adapted to include the heart and the thoracic and upper abdominal vessels of interest like ascending, transverse and descending aorta, main and branch pulmonary arteries, pulmonary veins, superior and inferior vena cava, celiac and superior mesenteric vessels. Velocity encoding (VENC) will be set at 150-500 cm/sec to encompass flow in various vessels.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4D PC MRI acquisition
Flow-sensitive 4D-MRI acquisitions will be synchronized to the heart rate and breathing using prospective ECG-gating and adaptive diaphragm navigator gating41. The MRI sequence will consist of a segmented k-space spoiled gradient echo sequence with interleaved 3D velocity encoding. Data will be acquired in a sagittal oblique 3D data volume individually adapted to include the heart and the thoracic and upper abdominal vessels of interest like ascending, transverse and descending aorta, main and branch pulmonary arteries, pulmonary veins, superior and inferior vena cava, celiac and superior mesenteric vessels. Velocity encoding (VENC) will be set at 150-500 cm/sec to encompass flow in various vessels.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to undergo an MRI examination without anesthesia or sedation.
* Ability to undergo an MRI examination using 'Feed-and-Sleep' technique39
Exclusion Criteria
* General contraindications for an MRI examination such as non-MRI compatible metallic implants, claustrophobia.
* Patients who require anaesthesia or sedation for MRI
1 Day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shi-Joon Yoo
Cardiac Radiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shi-Joon Yoo, MD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB1000050375
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.